Cardiac Wire #210 September 16, 2024
America’s Hypertension Problem | Why Not Screen For AFib
Cardiac Wire #209 September 12, 2024
AFib Across the U.S. | Early Cholesterol Control
Cardiac Wire #208 September 9, 2024
Continuing Beta-Blockers | AI Aortic Stenosis Screening
Cardiac Wire #207 September 5, 2024
Asundexian’s OCEANIC Setback | ESC 2024 Highlights
Cardiac Wire #206 September 3, 2024
Vutrisiran Shines | Hypertension Paradigm Shift
Cardiac Wire #205 August 29, 2024
Leqvio Monotherapy | TCM for Arrhythmia
Cardiac Wire #204 August 26, 2024
Tirzepatide Impact | Olpasiran Makes Waves
Cardiac Wire #203 August 22, 2024
J&J’s HFrEF Expansion | Edwards’ AR Acquisition
Cardiac Wire #202 August 19, 2024
Medicare Cuts | Hollywood Heart Attacks
Cardiac Wire #201 August 15, 2024
Rivus HU6 HFpEF Potential | A Case for HF Specialists
Cardiac Wire #200 August 12, 2024
Cardiology AI Clearances | CVAUSA’s Home Expansion
Cardiac Wire #199 August 8, 2024
Kerendia’s HF Impact | Heart Band-Aid
Cardiac Wire #198 August 5, 2024
Tirzepatide’s HFpEF Impact | Lp(a)’s Testing Lag
Cardiac Wire #197 August 1, 2024
Obicetrapib Cuts LDL-C | First Total Artificial Heart
Cardiac Wire #196 July 29, 2024
Edwards Acquisition Spree | Wegovy’s EU Expansion
Cardiac Wire #195 July 25, 2024
Magenta’s MCS Disruption | REVIVED CAD Evidence
Cardiac Wire #194 July 22, 2024
AFib Wearables’ Psychological Impact | Interactive Plaque
Cardiac Wire #193 July 18, 2024
Lexeo’s FA Cardiomyopathy Promise | Edwards Mitral Mission
Cardiac Wire #192 July 15, 2024